Balchem (BCPC) Cost of Revenue (2010 - 2026)

Balchem (BCPC) has 17 years of Cost of Revenue data on file, last reported at $169.6 million in Q1 2026.

• On a quarterly basis, Cost of Revenue rose 4.48% year-over-year to $169.6 million in Q1 2026; TTM through Mar 2026 was -$213.4 million, a 223.85% decrease from a year earlier, with the FY2025 full-year figure at $75.4 million, up 9.37% from the prior year.
• Cost of Revenue for Q1 2026 stood at $169.6 million, up from -$421.4 million in the prior quarter.
• Over the last five years, Cost of Revenue for BCPC reached as high as $565.3 million in Q4 2023 and fell as low as -$430.6 million in Q4 2022.
• Historically, Cost of Revenue has averaged $16.3 million across 5 years, with a median of $18.7 million in 2023.
• On a YoY basis, Cost of Revenue climbed as much as 769.74% in 2024 and fell as far as 169.86% in 2024.
• Year by year, Cost of Revenue stood at -$430.6 million in 2022, then jumped by 231.27% to $565.3 million in 2023, then sank by 169.86% to -$394.9 million in 2024, then decreased by 6.72% to -$421.4 million in 2025, then soared by 140.25% to $169.6 million in 2026.
• Per Business Quant data, the three most recent Cost of Revenue figures were $169.6 million in Q1 2026, -$421.4 million in Q4 2025, and $19.1 million in Q3 2025.